Tolerability, pharmacokinetics and preliminary antitumor activity of intravenous UNBS 1450 in patients with advanced solid tumours or lymphoma.
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2009
At a glance
- Drugs UNBS 1450 (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- Sponsors Unibioscreen
- 06 Mar 2008 New trial record.